Dr Agarwal's Eye Hospital Limited passed all six resolutions at its 32nd Annual General Meeting held on September 9, 2026, via video conferencing. The consolidated voting results were announced on September 10, 2026.

The meeting was chaired by Dr Amar Agarwal, Chairman cum Managing Director. Shareholders approved ordinary business items including the adoption of financial statements for FY26 and the declaration of a dividend of ₹4 per equity share (40%).

Voting Participation

A total of 55 members participated in the voting process for the first resolution. Remote e-voting was conducted from September 5 to September 8, 2026. The promoters and promoter group held 3,511,998 shares, representing a significant portion of the outstanding capital.

Key Resolutions Passed

Shareholders approved special business items involving remuneration revisions for senior leadership. The specific resolutions transacted are detailed below.

Voting Results Analysis

All resolutions received overwhelming support from the promoter group, which voted 100% in favour across all agenda items. Institutional public shareholders also voted unanimously in favour of all resolutions.

Minor dissent was observed among non-institutional public shareholders. For the adoption of financial statements, 97.88% of polled votes from this category were in favour, with 2.12% against. Similar patterns were seen for other resolutions, with dissent ranging between 2.11% and 2.16% among non-institutional public voters.

Mr Subramanian Chandrasekar served as the scrutinizer. The company confirmed that no invalid votes were recorded for any resolution.

Dr. Agarwal's Health Care launched the world’s first dedicated Pinhole Pupilloplasty (PPP) Centre at its flagship Alwarpet facility in Chennai on August 27, 2026. The Tamil Nadu Chief Minister, Thiru C. Joseph Vijay, inaugurated the centre.

The subsidiary, Dr. Agarwal's Eye Hospital Limited (AEHL), developed the facility to address complex corneal disorders without requiring donor tissue. Dr. Amar Agarwal, Chairman and Managing Director, and Dr. Manoj Khatri, Director – Vitreo-Retinal Services, were present at the event.

Clinical Innovation

The centre utilizes the Pinhole Pupilloplasty technique, developed by Dr. Amar Agarwal. This microsurgical procedure creates a small, precisely centred pupillary aperture to block scattered light rays. It improves functional vision for patients with corneal scars, irregular corneas, and high optical aberrations.

The procedure preserves the natural cornea, addressing the global shortage of donor tissue. A landmark international survey cited in the release noted that approximately 12.7 million people worldwide await corneal transplantation. Only one donor cornea is available for every 70 people in need. The survey further reported that approximately 185,000 corneal transplants were performed annually across 116 countries.

Patient Impact and Training

The hospital reports that the procedure has provided vision to over 5000 patients so far. The new centre will serve as a comprehensive programme encompassing diagnostics, surgery, research, and training.

More than 50 ophthalmologists undergo training through workshops and academic programmes every year. The facility aims to teach specialists how to identify appropriate candidates for this tissue-preserving solution.

Community Initiatives

The launch coincides with the 41st National Eye Donation Fortnight. Earlier, to mark the birthday of Chief Minister Thiru C. Joseph Vijay, the hospital screened more than 16,000 schoolchildren across Tamil Nadu in a single day.

Dr. Manoj Khatri stated that innovation becomes meaningful when it changes a patient’s everyday life. The centre represents a step towards restoring useful vision while preserving precious donor tissue for those who need it most.